Ablation of Atrial Fibrillation in Patients with Hypertension-An Analysis from the German Ablation Registry.
arterial hypertension
atrial fibrillation
catheter ablation
complications
long-term follow-up
registry
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
27 Jul 2020
27 Jul 2020
Historique:
received:
24
06
2020
revised:
21
07
2020
accepted:
22
07
2020
entrez:
31
7
2020
pubmed:
31
7
2020
medline:
31
7
2020
Statut:
epublish
Résumé
Hypertension (HTN) constitutes a risk factor for the development of atrial fibrillation (AF), as well as for thromboembolic and bleeding events. We analysed the outcome after catheter ablation of AF in HTN in a cohort from the prospective multicenter German Ablation Registry. Between 03/2008 and 01/2010, 626 patients undergoing AF-ablation were analysed. Patients diagnosed with HTN ( Patients with HTN were older and more often presented with persistent forms of AF and cardiac comorbidities. Major and moderate in-hospital complications were low. At long-term follow-up, major cardiovascular events were rare in both groups. Rates of AF-recurrence, freedom from antiarrhythmic medication and repeat ablation were not statistically different between groups. Most patients reported improvement of symptoms and satisfaction with the treatment. However, patients with HTN more frequently complained of dyspnea of New York Heart Association (NYHA) class ≥ II and angina. They were more often rehospitalized, particularly when persistent AF had been diagnosed. Catheter ablation of AF is associated with low complication rates and favorable arrhythmia-related results in patients with HTN. Residual clinical symptoms may be due to cardiac comorbidities and require additional attention in this important subgroup of AF-patients.
Sections du résumé
BACKGROUND
BACKGROUND
Hypertension (HTN) constitutes a risk factor for the development of atrial fibrillation (AF), as well as for thromboembolic and bleeding events. We analysed the outcome after catheter ablation of AF in HTN in a cohort from the prospective multicenter German Ablation Registry.
METHODS
METHODS
Between 03/2008 and 01/2010, 626 patients undergoing AF-ablation were analysed. Patients diagnosed with HTN (
RESULTS
RESULTS
Patients with HTN were older and more often presented with persistent forms of AF and cardiac comorbidities. Major and moderate in-hospital complications were low. At long-term follow-up, major cardiovascular events were rare in both groups. Rates of AF-recurrence, freedom from antiarrhythmic medication and repeat ablation were not statistically different between groups. Most patients reported improvement of symptoms and satisfaction with the treatment. However, patients with HTN more frequently complained of dyspnea of New York Heart Association (NYHA) class ≥ II and angina. They were more often rehospitalized, particularly when persistent AF had been diagnosed.
CONCLUSION
CONCLUSIONS
Catheter ablation of AF is associated with low complication rates and favorable arrhythmia-related results in patients with HTN. Residual clinical symptoms may be due to cardiac comorbidities and require additional attention in this important subgroup of AF-patients.
Identifiants
pubmed: 32727136
pii: jcm9082402
doi: 10.3390/jcm9082402
pmc: PMC7463680
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Stiftung Institut für Herzinfarktforschung
ID : unrestricted grant
Organisme : Medtronic
ID : unrestricted grant
Organisme : Biosense Webster
ID : unrestricted grand
Organisme : Biotronik
ID : unrestricted grant
Références
J Am Coll Cardiol. 2009 Nov 24;54(22):2023-31
pubmed: 19926008
Clin Res Cardiol. 2020 Jun;109(6):787-789
pubmed: 31784901
Am Heart J. 2016 Aug;178:74-84
pubmed: 27502854
Eur Heart J. 2018 Feb 7;39(6):442-449
pubmed: 29020388
JAMA. 1994 Mar 16;271(11):840-4
pubmed: 8114238
Chest. 2010 Nov;138(5):1093-100
pubmed: 20299623
J Am Coll Cardiol. 2010 Feb 23;55(8):725-31
pubmed: 20170808
Lancet. 1999 Nov 20;354(9192):1751-6
pubmed: 10577635
J Hypertens. 2012 Feb;30(2):239-52
pubmed: 22186358
Europace. 2008 Feb;10(2):238-41
pubmed: 18256129
Circulation. 2017 May 9;135(19):1788-1798
pubmed: 28228428
Clin Res Cardiol. 2020 Jun;109(6):714-724
pubmed: 31667623
Cardiovasc Res. 2015 Apr 1;106(1):87-97
pubmed: 25691541
J Am Coll Cardiol. 2010 May 25;55(21):2299-307
pubmed: 20488299
Hypertension. 2003 Feb;41(2):218-23
pubmed: 12574085
Circ Arrhythm Electrophysiol. 2011 Oct;4(5):761-9
pubmed: 21862733
PLoS One. 2013 Aug 27;8(8):e72416
pubmed: 24013508
N Engl J Med. 2011 Sep 15;365(11):981-92
pubmed: 21870978
Circulation. 2011 Apr 12;123(14):1501-8
pubmed: 21444879
N Engl J Med. 2013 Nov 28;369(22):2093-104
pubmed: 24251359
J Am Heart Assoc. 2015 Dec 01;4(12):
pubmed: 26627878
Eur Heart J Cardiovasc Pharmacother. 2017 Oct 1;3(4):235-250
pubmed: 28541499
Eur Heart J. 2006 Dec;27(24):3045-56
pubmed: 17098760
JACC Clin Electrophysiol. 2015 Jun;1(3):164-173
pubmed: 29759360
J Am Coll Cardiol. 2002 Nov 6;40(9):1636-44
pubmed: 12427417
J Cardiovasc Electrophysiol. 2011 Nov;22(11):1206-14
pubmed: 21668562
N Engl J Med. 2016 Jun 9;374(23):2235-45
pubmed: 27042964
N Engl J Med. 2012 Jan 12;366(2):120-9
pubmed: 22236222
Chest. 2010 Feb;137(2):263-72
pubmed: 19762550
Am Heart J. 2007 Sep;154(3):448-53
pubmed: 17719288
Pacing Clin Electrophysiol. 2018 Apr;41(4):402-410
pubmed: 29446840
Hypertension. 2013 Apr;61(4):786-92
pubmed: 23438932
N Engl J Med. 2011 Sep 8;365(10):883-91
pubmed: 21830957
Heart Rhythm. 2010 Sep;7(9):1282-90
pubmed: 20466075
Curr Probl Cardiol. 2020 May 22;:100622
pubmed: 32571567
Ann Intern Med. 2010 Jan 19;152(2):78-84
pubmed: 20083826
N Engl J Med. 2009 Sep 17;361(12):1139-51
pubmed: 19717844
JACC Clin Electrophysiol. 2017 May;3(5):461-469
pubmed: 29759601